{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:43:07Z","timestamp":1789411387038,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Schistosoma mansoni<\/jats:italic> is less susceptible to the antiparasitic drug ivermectin than other helminths. By inhibiting the P-glycoprotein or cytochrome P450 3A in mice host or parasites in a murine model, we aimed at increasing the sensitivity of <jats:italic>S. mansoni<\/jats:italic> to the drug and thus preventing infection. We assigned 124 BALB\/c mice to no treatment, treatment with ivermectin only or a combination of ivermectin with either cobicistat or elacridar once daily for three days before infecting them with 150 <jats:italic>S. mansoni<\/jats:italic> cercariae each. The assignment was done by batches without an explicit randomization code. Toxicity was monitored. At eight weeks post-infection, mice were euthanized. We determined number of eggs in intestine and liver, adult worms in portal and mesenteric veins. Disease was assessed by counting granulomas\/cm<jats:sup>2<\/jats:sup> of liver and studying organ weight indices and total weight. IgG levels in serum were also considered. No difference between groups treated with ivermectin only or in combination with cobicistat or elacridar compared with untreated, infected controls. Most mice treated with ivermectin and elacridar suffered severe neurological toxicity. In conclusion, systemic treatment with ivermectin, even in the presence of pharmacological inhibition of P-glycoprotein or cytochrome P450 3A, did not result in effective prophylaxis for <jats:italic>S. mansoni<\/jats:italic> infection in an experimental murine model.<\/jats:p>","DOI":"10.1038\/s41598-021-84009-y","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:03:35Z","timestamp":1614164615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Bel\u00e9n","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"L\u00f3pez-Ab\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Chaccour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hern\u00e1ndez-Goenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Fern\u00e1ndez-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chaccour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"84009_CR1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","volume":"111","author":"W Wang","year":"2012","unstructured":"Wang, W., Wang, L. & Liang, Y.-S. Susceptibility or resistance of praziquantel in human schistosomiasis: A review. Parasitol. Res. [Internet] 111, 1871\u20131877. https:\/\/doi.org\/10.1007\/s00436-012-3151-z (2012).","journal-title":"Parasitol. Res. [Internet]"},{"key":"84009_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3109\/13880209.2014.970289","volume":"53","author":"WM Lotfy","year":"2015","unstructured":"Lotfy, W. M., Hishmat, M. G., El Nashar, A. S. & Abu El Einin, H. M. Evaluation of a method for induction of praziquantel resistance in Schistosomamansoni. Pharm. Biol. [Internet] 53, 1214\u20131219. https:\/\/doi.org\/10.3109\/13880209.2014.970289 (2015).","journal-title":"Pharm. Biol. [Internet]"},{"key":"84009_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actatropica.2005.07.010","volume":"96","author":"SH Xiao","year":"2005","unstructured":"Xiao, S. H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop. 96, 153\u2013167 (2005).","journal-title":"Acta Trop."},{"key":"84009_CR4","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1371\/journal.pntd.0000350","volume":"3","author":"J Keiser","year":"2009","unstructured":"Keiser, J. et al. Mefloquine\u2014An aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. [Internet] 3, e350. https:\/\/doi.org\/10.1371\/journal.pntd.0000350 (2009).","journal-title":"PLoS Negl. Trop. Dis. [Internet]"},{"key":"84009_CR5","doi-asserted-by":"publisher","first-page":"e109431","DOI":"10.1371\/journal.pone.0109431","volume":"9","author":"E Yepes","year":"2014","unstructured":"Yepes, E. et al. In vitro and in vivo ant-schistosomal activity of the alkylphospholipid analog edelfosine. PLoS ONE 9, e109431 (2014).","journal-title":"PLoS ONE"},{"key":"84009_CR6","doi-asserted-by":"publisher","first-page":"e0003893","DOI":"10.1371\/journal.pntd.0003893","volume":"9","author":"E Yepes","year":"2015","unstructured":"Yepes, E. et al. Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and praziquantel. PLoS Negl. Trop. Dis. [Internet] 9, e0003893. https:\/\/doi.org\/10.1371\/journal.pntd.0003893 (2015).","journal-title":"PLoS Negl. Trop. Dis. [Internet]"},{"key":"84009_CR7","doi-asserted-by":"crossref","unstructured":"\u014cmura, S. & Crump, A. Ivermectin: panacea for resource-poor communities? Trends Parasitol. [Internet] 30, 445\u2013455. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1471492214001263 (2014).","DOI":"10.1016\/j.pt.2014.07.005"},{"key":"84009_CR8","unstructured":"Merck. Stromectrol. TGA-Australia approved Package insert [Internet]. 2014 [cited 31 Aug 2020]. https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2011-PI-02659-3&d=2016071016114622483."},{"key":"84009_CR9","first-page":"817","volume":"2","author":"A Taman","year":"2014","unstructured":"Taman, A., El-Beshbibi, S., El-Tantawy, N., El-Hawary, A. & Azab, M. Evaluation of the in vivo effect of ivermectin on Schistosoma mansoni in experimentally-infected mice. J. Coast Life Med. 2, 817\u2013823 (2014).","journal-title":"J. Coast Life Med."},{"key":"84009_CR10","doi-asserted-by":"publisher","first-page":"e1003586","DOI":"10.1371\/journal.ppat.1003586","volume":"9","author":"V Dufour","year":"2013","unstructured":"Dufour, V., Beech, R. N., Wever, C., Dent, J. A. & Geary, T. G. Molecular cloning and characterization of novel glutamate-gated chloride channel subunits from Schistosomamansoni. PLOS Pathog. [Internet] 9, e1003586. https:\/\/doi.org\/10.1371\/journal.ppat.1003586 (2013).","journal-title":"PLOS Pathog. [Internet]"},{"key":"84009_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3347\/kjp.2013.51.2.165","volume":"51","author":"SH Seif El-Din","year":"2013","unstructured":"Seif El-Din, S. H., Abdel-Aal Sabra, A.-N., Hammam, O. A. & El-Lakkany, N. M. Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosomamansoni in mice. Korean J. Parasitol. [Internet] 51, 165\u2013175 (2013).","journal-title":"Korean J. Parasitol. [Internet]"},{"key":"84009_CR12","doi-asserted-by":"publisher","first-page":"e0004279","DOI":"10.1371\/journal.pntd.0004279","volume":"9","author":"PD Ziniel","year":"2016","unstructured":"Ziniel, P. D. et al. The Schistosomamansoni cytochrome P450 (CYP3050A1) is essential for worm survival and egg development. PLoS Negl. Trop. Dis. [Internet] 9, e0004279. https:\/\/doi.org\/10.1371\/journal.pntd.0004279 (2016).","journal-title":"PLoS Negl. Trop. Dis. [Internet]"},{"key":"84009_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-4017(99)00053-9","volume":"83","author":"JL Ab\u00e1n","year":"1999","unstructured":"Ab\u00e1n, J. L. et al. A fatty acid binding protein from Fasciola hepatica induced protection in C57\/BL mice from challenge infection with Schistosoma bovis. Vet Parasitol. Netherlands 83, 107\u2013121 (1999).","journal-title":"Vet Parasitol. Netherlands"},{"key":"84009_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0006-2952(02)01358-8","volume":"64","author":"DL Mendon\u00e7a-Silva","year":"2002","unstructured":"Mendon\u00e7a-Silva, D. L., Fittpaldi Pess\u00f4a, R. & No\u00ebl, F. Evidence for the presence of glutamatergic receptors in adult Schistosomamansoni. Biochem. Pharmacol. 64, 1337\u20131344 (2002).","journal-title":"Biochem. Pharmacol."},{"key":"84009_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijpddr.2011.09.003","volume":"1","author":"A Wolstenholme","year":"2011","unstructured":"Wolstenholme, A. Ion channels and receptor as targets for the control of parasitic nematodes. Int. J. Parasitol. Drugs Drug Resist. 1, 2\u201313 (2011).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"84009_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S0031182000076149","volume":"108","author":"JM Solis-Soto","year":"1994","unstructured":"Solis-Soto, J. M. & de Jong-Brink, M. Immunocytochemical study on biologically active neurosubstances i daughter sporocysts and cercariae of Trichobilharziaocellata and Schistosomamansoni. Parasitology 108, 301\u2013311 (1994).","journal-title":"Parasitology"},{"key":"84009_CR17","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1038\/s41598-020-74084-y","volume":"10","author":"C Chaccour","year":"2020","unstructured":"Chaccour, C. et al. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. Sci. Rep. [Internet] 10, 17073. https:\/\/doi.org\/10.1038\/s41598-020-74084-y (2020).","journal-title":"Sci. Rep. [Internet]"},{"key":"84009_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpara.2008.06.009","volume":"39","author":"C James","year":"2009","unstructured":"James, C. & Davey, M. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditiselegans. Int. J. Parasitol. 39, 213\u2013220 (2009).","journal-title":"Int. J. Parasitol."},{"key":"84009_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.vetpar.2012.09.021","volume":"191","author":"B Ardelli","year":"2013","unstructured":"Ardelli, B. & Prichard, R. Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditiselegans to ivermectin. Vet. Parasitol. 191, 264\u2013275 (2013).","journal-title":"Vet. Parasitol."},{"key":"84009_CR20","doi-asserted-by":"publisher","first-page":"8535","DOI":"10.1038\/s41598-017-08906-x","volume":"7","author":"C Chaccour","year":"2017","unstructured":"Chaccour, C. et al. Cytochrome P450\/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anophelesgambiae. Sci. Rep. 7, 8535 (2017).","journal-title":"Sci. Rep."},{"key":"84009_CR21","doi-asserted-by":"publisher","first-page":"e3265","DOI":"10.1371\/journal.pntd.0003265","volume":"8","author":"RS Kasinathan","year":"2014","unstructured":"Kasinathan, R. S., Sharma, L. K., Cunningham, C., Webb, T. R. & Greenberg, R. M. Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to praziquantel. PLoS Negl. Trop. Dis. [Internet] 8, e3265. https:\/\/doi.org\/10.1371\/journal.pntd.0003265 (2014).","journal-title":"PLoS Negl. Trop. Dis. [Internet]"},{"key":"84009_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2010.09-0734","volume":"83","author":"C Bourguinat","year":"2010","unstructured":"Bourguinat, C. et al. Analysis of the mdr-1 gene in patients co-infected with Onchocercavolvulus and Loaloa who experienced a post-ivermectin serious adverse event. Am. J. Trop. Med. Hyg. 83, 28\u201332 (2010).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"84009_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel, A. H. et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs. Cell [Internet] 77, 491\u2013502. https:\/\/doi.org\/10.1016\/0092-8674(94)90212-7 (1994).","journal-title":"Cell [Internet]"},{"key":"84009_CR24","doi-asserted-by":"crossref","unstructured":"Mealey, K. L., Bentjen, S. A., Gay, J. M. & Cantor, G. H. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenet. Genomics [Internet]. 2001;11. https:\/\/journals.lww.com\/jpharmacogenetics\/Fulltext\/2001\/11000\/Ivermectin_sensitivity_in_collies_is_associated.12.aspx","DOI":"10.1097\/00008571-200111000-00012"},{"key":"84009_CR25","first-page":"288","volume":"49","author":"JA Davis","year":"1999","unstructured":"Davis, J. A. et al. Behavioral effects of ivermectin in mice. Lab. Anim. Sci. 49, 288\u2013296 (1999).","journal-title":"Lab. Anim. Sci."},{"key":"84009_CR26","unstructured":"BV Dohme Merck Sharp & Stromectol. FDA-approved package insert [Internet]. 2007 [cited 6 Oct 2020]. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/s\/stromectol\/stromectol_pi.pdf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84009-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:24:44Z","timestamp":1670041484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84009-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84009"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84009-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4476"}}